首页> 外文期刊>Critical care nursing clinics of North America >Interpreting Laboratory Tests in Infection Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients
【24h】

Interpreting Laboratory Tests in Infection Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients

机译:解读脓毒症生物标志物感染的实验室检验,并为重症监护单位患者进行生物标志物感和全身炎症反应综合征

获取原文
获取原文并翻译 | 示例
       

摘要

Sepsis and severe sepsis are leading causes of death in the United States and the most common causes of death among critically ill patients in non coronary intensive care units. Diagnosis of infection and sepsis is a subjective clinical judgment based on the criteria for systemic inflammatory reaction, which is highly sensitive, not specific, and often misleading in intensively treated patients. Biomarkers are emerging as adjuncts to traditional diagnostic measures. No biomarkers have sufficient specificity or sensitivity to be routinely used in clinical practice, but they can aid in the diagnosis and treatment of infection versus inflammation.
机译:脓毒症和严重脓毒症是美国的死亡原因,以及非冠状动脉密集护理单位的危重病患者患者中最常见的死亡原因。 感染和败血症的诊断是基于全身炎症反应标准的主观临床判断,这是高度敏感的,不具体的,并且在强烈治疗的患者中经常误导。 生物标志物正在出现传统诊断措施的辅助。 没有生物标志物具有足够的特异性或敏感性来常规用于临床实践,但它们可以帮助诊断和治疗感染与炎症的诊断和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号